期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients
1
作者 Li Liua Xiaolei Peia +10 位作者 Runzhi Maa Yi Hea Rongli Zhanga Jialin Weia Qiaoling Maa weihua zhaia Aiming Pang Erlie Jiang Mingzhe Han Donglin Yang Sizhou Feng 《Blood Science》 2023年第2期106-110,共5页
Invasive fungal diseases(IFDs)are major and lethal infectious complications for patients with neutropenia after chemotherapy.Prophylaxis with intravenous and oral suspended itraconazole(200 mg Q12h intravenously×... Invasive fungal diseases(IFDs)are major and lethal infectious complications for patients with neutropenia after chemotherapy.Prophylaxis with intravenous and oral suspended itraconazole(200 mg Q12h intravenously×2 days followed by 5 mg/kg·d orally in twice)or oral suspension of posaconazole(200 mg Q8h)was administered for preventing IFDs.The only 2 episodes of proven IFDs were not included after propensity-score matching(PSM),while the incidence of possible IFDs was 8.2%(9/110)in itraconazole group and 1.8%(2/110)in posaconazole group,respectively(P=.030).In clinical failure analysis,the failure rate of posaconazole group was lower as compared to the itraconazole group(2.7%vs 10.9%,P=.016).Both intravenous-oral itraconazole and posaconazole suspension are effective in preventing IFDs,while posaconazole suspension seems more tolerable. 展开更多
关键词 Acute leukemia Antifungal prophylaxis Invasive fungal disease ITRACONAZOLE POSACONAZOLE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部